Angion Biomedica (NASD: ANGN) CEO Focus on Primary Proteinuric Kidney Diseases
Interview with Jay Venkatesan, M.D., the President, Chief Executive Officer, and Chairman of Angion Biomedica Corp. (ANGN).
Stay updated with breaking news from Bayer Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interview with Jay Venkatesan, M.D., the President, Chief Executive Officer, and Chairman of Angion Biomedica Corp. (ANGN).
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Amunix Announces the Appointment of Healthcare Investment Banking Veteran Zeeshan Merchant as ... Amunix Pharmaceuticals, Inc.January 26, 2021 GMT SOUTH SAN FRANCISCO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Amunix Pharmaceuticals, Inc. (“Amunix”), a biopharmaceutical company focused on developing prodrugs to bring the promise of potent immune-activating biotherapeutics to patients with solid tumor cancers, today announced the appointment of Zeeshan Merchant as Chief Financial Officer and Tris...